ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "c3f0ba2d-3a2b-42f8-a387-89bf264cbb44"}, "_deposit": {"id": "21634", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "21634"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00021634", "sets": ["456", "1189"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "New Drugs for DIC"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1991-02", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "2", "bibliographicPageEnd": "108", "bibliographicPageStart": "103", "bibliographicVolumeNumber": "105", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Heparin has long been used for disseminated intravascular coagulation (DIC), but recently some new drugs have become available for DIC. The concentrate of Antithrombin III, which is a physiological protease inhibitor, is used in combination with heparin. Low molecular weight heparin (LMWH) with molecular weight of about 4000~6000 has more anti-X_a activity than anti-IIa activity. For this reason, LMWH has an anticoagulant activity with a low bleeding risk. Synthetic protease inhibitors (eg. FUTHAN) directly inhibit several protease activities in the absence of antithrombin III. Activated protein C inactivates V_a and VIII_a with protein S as a cofactor, and inhibits plasminogen activator inhibitor. Its concentrate may be effective for patients with DIC especially caused by endotoxicemia. DIC is heterogeneous in coagulation-fibrinolysis balance and is associated with various diseases, so we must choose suitable drugs for individual patients.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "132009", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Tatewaki, Wataru"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "帯刀, 亘"}], "nameIdentifiers": [{"nameIdentifier": "132008", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-16"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "105(2)_103-108.pdf", "filesize": [{"value": "1.3 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1300000.0, "url": {"label": "105(2)_103-108.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/21634/files/105(2)_103-108.pdf"}, "version_id": "89d1954a-09b9-46fd-be64-69866c11483e"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "low molecular weight heparin", "subitem_subject_scheme": "Other"}, {"subitem_subject": "synthetic protease inhibitor", "subitem_subject_scheme": "Other"}, {"subitem_subject": "activated protein C", "subitem_subject_scheme": "Other"}, {"subitem_subject": "低分子ヘパリン", "subitem_subject_scheme": "Other"}, {"subitem_subject": "合成蛋白分解酵素阻害剤", "subitem_subject_scheme": "Other"}, {"subitem_subject": "活性化プロテインC", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "5) DICの新しい治療薬F(シンポジウム DIC-診断・治療の最近の動向, 第457回新潟医学会)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "5) DICの新しい治療薬F(シンポジウム DIC-診断・治療の最近の動向, 第457回新潟医学会)"}, {"subitem_title": "5) DICの新しい治療薬F(シンポジウム DIC-診断・治療の最近の動向, 第457回新潟医学会)", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1189"], "permalink_uri": "http://hdl.handle.net/10191/38609", "pubdate": {"attribute_name": "公開日", "attribute_value": "2016-02-22"}, "publish_date": "2016-02-22", "publish_status": "0", "recid": "21634", "relation": {}, "relation_version_is_last": true, "title": ["5) DICの新しい治療薬F(シンポジウム DIC-診断・治療の最近の動向, 第457回新潟医学会)"], "weko_shared_id": null}
  1. 0 資料タイプ別
  2. 03 紀要論文
  1. 250 大学院医歯学総合研究科(医)
  2. 20 紀要
  3. 02 新潟医学会雑誌
  4. 第105巻第2号

5) DICの新しい治療薬F(シンポジウム DIC-診断・治療の最近の動向, 第457回新潟医学会)

http://hdl.handle.net/10191/38609
http://hdl.handle.net/10191/38609
3de8fd66-259c-4018-a4ad-5e5ed50b6d6c
名前 / ファイル ライセンス アクション
105(2)_103-108.pdf 105(2)_103-108.pdf (1.3 MB)
Item type 紀要論文 / Departmental Bulletin Paper(1)
公開日 2016-02-22
タイトル
タイトル 5) DICの新しい治療薬F(シンポジウム DIC-診断・治療の最近の動向, 第457回新潟医学会)
タイトル
言語 en
タイトル 5) DICの新しい治療薬F(シンポジウム DIC-診断・治療の最近の動向, 第457回新潟医学会)
言語
言語 jpn
キーワード
主題Scheme Other
主題 low molecular weight heparin
キーワード
主題Scheme Other
主題 synthetic protease inhibitor
キーワード
主題Scheme Other
主題 activated protein C
キーワード
主題Scheme Other
主題 低分子ヘパリン
キーワード
主題Scheme Other
主題 合成蛋白分解酵素阻害剤
キーワード
主題Scheme Other
主題 活性化プロテインC
資源タイプ
資源 http://purl.org/coar/resource_type/c_6501
タイプ departmental bulletin paper
その他のタイトル
その他のタイトル New Drugs for DIC
著者 帯刀, 亘

× 帯刀, 亘

WEKO 132008

帯刀, 亘

Search repository
著者別名
識別子 132009
識別子Scheme WEKO
姓名 Tatewaki, Wataru
抄録
内容記述タイプ Abstract
内容記述 Heparin has long been used for disseminated intravascular coagulation (DIC), but recently some new drugs have become available for DIC. The concentrate of Antithrombin III, which is a physiological protease inhibitor, is used in combination with heparin. Low molecular weight heparin (LMWH) with molecular weight of about 4000~6000 has more anti-X_a activity than anti-IIa activity. For this reason, LMWH has an anticoagulant activity with a low bleeding risk. Synthetic protease inhibitors (eg. FUTHAN) directly inhibit several protease activities in the absence of antithrombin III. Activated protein C inactivates V_a and VIII_a with protein S as a cofactor, and inhibits plasminogen activator inhibitor. Its concentrate may be effective for patients with DIC especially caused by endotoxicemia. DIC is heterogeneous in coagulation-fibrinolysis balance and is associated with various diseases, so we must choose suitable drugs for individual patients.
書誌情報 新潟医学会雑誌
en : 新潟医学会雑誌

巻 105, 号 2, p. 103-108, 発行日 1991-02
出版者
出版者 新潟医学会
ISSN
収録物識別子タイプ ISSN
収録物識別子 00290440
書誌レコードID
収録物識別子タイプ NCID
収録物識別子 AN00182415
著者版フラグ
値 publisher
戻る
0
views
See details
Views

Versions

Ver.1 2021-03-01 13:37:18.022359
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3